Kim Hak Min, Kang Dong Il, Shim Bong Suk, Min Kweon Sik
Department of Urology, Inje University College of Medicine, Busan, Korea.
Korean J Urol. 2010 Dec;51(12):853-7. doi: 10.4111/kju.2010.51.12.853. Epub 2010 Dec 21.
The clinical usefulness of hyaluronic acid (HA) instillation during visual internal urethrotomy (VIU) for decreasing the incidence of recurrent urethral stricture was assessed.
Twenty-eight patients were treated by VIU with HA instillation between May 2007 and June 2009. After insertion of a Foley catheter following urethrotomy, HA was instilled via an 18-gauge tube catheter between the urethral lumen and Foley catheter. Seventeen cases were analyzed retrospectively 12 months postoperatively. We evaluated the success rate of this procedure by comparing retrograde urethrography (RGU) results, maximum flow rates, and postvoid residual urine volumes preoperatively and 3 and 12 months postoperatively. Success was defined as either a maximum flow rate of at least 15 ml/s or no visible urethral stricture on RGU at 12 months postoperatively.
Total success rates were 76.5% (13/17) and 52.9% (9/17) at 3 and 12 months postoperatively, respectively. By etiology, success rates at 3 and 12 months postoperatively, respectively, were 66.7% and 33.3% for inflammation, 66.7% and 50.0% for trauma, and 83.3% and 66.7% for unknown causes. Success rates were 63.6% for strictures less than 10 mm in length and 33.3% for strictures of 10 mm or more in length at 12 months postoperatively. Success rates were 61.5% for single strictures and 25% for multiple strictures at 12 months postoperatively.
The success rate of VIU with HA instillation was not better than that observed in the literature for conventional VIU.
评估在直视下尿道内切开术(VIU)期间注入透明质酸(HA)以降低复发性尿道狭窄发生率的临床实用性。
2007年5月至2009年6月期间,28例患者接受了VIU并注入HA治疗。尿道切开术后插入Foley导尿管,通过一根18号管形导管在尿道腔和Foley导尿管之间注入HA。17例患者在术后12个月进行回顾性分析。我们通过比较术前、术后3个月和12个月的逆行尿道造影(RGU)结果、最大尿流率和残余尿量来评估该手术的成功率。成功定义为术后12个月时最大尿流率至少为15 ml/s或RGU上无可见尿道狭窄。
术后3个月和12个月时的总成功率分别为76.5%(13/17)和52.9%(9/17)。按病因分类,术后3个月和12个月时,炎症的成功率分别为66.7%和33.3%,创伤的成功率分别为66.7%和50.0%,不明原因的成功率分别为83.3%和66.7%。术后12个月时,长度小于10 mm的狭窄成功率为63.6%,长度为10 mm或更长的狭窄成功率为33.3%。术后12个月时,单发狭窄的成功率为61.5%,多发狭窄的成功率为25%。
注入HA的VIU成功率并不优于文献中报道的传统VIU的成功率。